Stay updated with breaking news from Laurae niklason. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Humacyte (NASDAQ:HUMA) Issues Quarterly Earnings Results theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald Weighs in on Humacyte, Inc.'s FY2024 Earnings (NASDAQ:HUMA) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald started coverage on shares of Humacyte (NASDAQ:HUMA – Get Rating) in a report published on Thursday, The Fly reports. The brokerage issued an overweight rating and a $6.00 target price on the stock. Separately, Benchmark reissued a buy rating and issued a $16.00 price objective on shares of Humacyte in a research report […] ....
Humacyte, Inc. (NASDAQ:HUMA – Get Rating) CEO Laura E. Niklason sold 500,000 shares of the business’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $3.12, for a total transaction of $1,560,000.00. Following the transaction, the chief executive officer now directly owns 9,990,736 shares in the company, […] ....
Humacyte, Inc. (NASDAQ:HUMA – Get Rating) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 5,520,000 shares, an increase of 5.7% from the April 30th total of 5,220,000 shares. Based on an average daily volume of 262,600 shares, the days-to-cover ratio is presently […] ....